Symbiox Investment & Trading Company Ltd (SYMBIOX) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Symbiox Investment & Trading Company Ltd ₹0.87, price ₹1.52, upside -42.8%, quality 73 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Symbiox Investment & Trading Company Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.
How to read this chart
60‑month range ₹0.7500 – ₹15.57 · fair‑value band ₹0.6700 – ₹1.06 · the ₹1.52 price screens above the ₹0.8700 fair value. Dashed = 300-day average. As of Sep 29, 2026.
Follow Symbiox Investment & Trading Company in your weekly email
Every Wednesday you see whether Symbiox Investment & Trading Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Symbiox Investment & Trading Co Ltd engages in the trading of textile products in India.
Show more
Symbiox Investment & Trading Co Ltd engages in the trading of textile products in India. The company offers traditional handloom, handicrafts, wool and silk products; gunny, hessian, carper backing, tarpoline cloth, jute cutting, raw jute, and textile; and fabrics, garments, carpets, durries, mats, rugs, blankets, shawls, tweeds, linens, flannels, bed spreads, quilts, scares, belts, furnishing and all sorts of apparels dressing materials mixed nylon, polyester, fiber, yarn, hosiery and mixed fabrics natural silk fabrics and garments. It deals in shares, stocks, debentures, bonds, and obligations and securities issued or guarantees. The company sells its products through wholesalers and retailers. Symbiox Investment & Trading Co. Ltd. was incorporated in 1979 and is based in Kolkata, India.
Stock analysis
Symbiox Investment & Trading Company Ltd (SYMBIOX) currently trades at ₹1.52, while our model-based Fair Value estimate is ₹0.8700, 42.8% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ₹6.83 per share, and 10 of the 20 models we run sit above the ₹1.52 price.
Bear case: the Earnings-Based group reads lowest at ₹0.4000, and 10 of the 20 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹0.6700 (bear) to ₹1.06 (bull), the price of ₹1.52 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 73/100 (solid quality), in the Consumer Cyclical sector.
Mixed Growth: Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.
Symbiox Investment & Trading Company Ltd reported revenue of ₹16.0M in FY2025 versus ₹10.5M in FY2021, a compound +11.1%/yr. Reported net income was ₹1.5M in FY2025, compounding +2.3%/yr from FY2021.
Key figures
Market cap ₹62.6M (≈ $650K) · P/E ratio 30.4 · P/S ratio 2.89 · EPS (TTM) ₹0.0500 · Net margin 9.5% · Return on equity 0.5% · Return on assets (EBIT) 0.0% · Operating margin 40.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 58% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −19% fair-value upside, at −43%, SYMBIOX screens richer than that median.
Fair Value models
Bear ₹0.6700Fair Value ₹0.8700Bull ₹1.06
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (₹0.0378 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+17.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+17.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.17.0% vs 3.1%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−44% → 13%
Compare Symbiox Investment & Trading Company Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 333 stocks
Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score73 · Top 25%
Fair Value upside+32.9% · Above median
Profitability
Return on equity (TTM)0.5% · Below median
Return on assets0.4% · Below median
Net margin (TTM)11.6% · Top 25%
Operating margin (TTM)40.9% · Top 25%
Growth and dividend
Revenue growth−44.3% · Bottom 25%
Valuation Multiplesvs Textile Manufacturing median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Symbiox Investment & Trading Company Ltd Fair Value". https://www.fairvalue-calculator.com/stock/SYMBIOX
Frequently asked questions
Is Symbiox Investment & Trading Company Ltd (SYMBIOX) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of ₹0.8700 versus a price of ₹1.52, about −43% upside (overvalued).
What is the fair value of SYMBIOX?
Our model-based fair value for Symbiox Investment & Trading Company Ltd is ₹0.8700 (as of Sep 29, 2026), built from audited fundamentals. The current price: ₹1.52.
What is the quality score of SYMBIOX?
Symbiox Investment & Trading Company Ltd has a Quality Score of 73/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Symbiox Investment & Trading Company Ltd (SYMBIOX)?
Our model-based price target is the fair value of ₹0.8700 (as of Sep 29, 2026) from 20 valuation models. Cautious scenario ₹0.6700, optimistic scenario ₹1.06. It is a calculation from audited fundamentals, not an analyst target.
What is the Symbiox Investment & Trading Company Ltd stock forecast for 2026?
Our models put fair value at ₹0.8700, about −43% upside versus a price of ₹1.52 (overvalued). Cautious scenario ₹0.6700, optimistic scenario ₹1.06. The calculation is refreshed regularly with new filings.
What is the revenue of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
Symbiox Investment & Trading Company Ltd reported trailing-twelve-month revenue of about ₹14.0M (latest available figure, as of Sep 29, 2026).
What is the intrinsic value of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Symbiox Investment & Trading Company Ltd it is ₹0.8700 per share (as of Sep 29, 2026), against a price of ₹1.52. It is the blended result of 20 valuation models (cash flow, earnings, asset, dividend).
Is Symbiox Investment & Trading Company Ltd stock overvalued or undervalued in 2026?
As of Sep 29, 2026, SYMBIOX trades above its calculated fair value: price ₹1.52, fair value ₹0.8700, a gap of about −43% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SYMBIOX?
No. The price is what the market pays today (₹1.52); the fair value is what the company's own numbers justify (₹0.8700). For Symbiox Investment & Trading Company Ltd the two are ₹0.6500 per share apart. That gap is exactly why we show both numbers side by side.
How much is Symbiox Investment & Trading Company Ltd worth?
The market values Symbiox Investment & Trading Company Ltd at about ₹62.6M (market capitalisation, as of Sep 29, 2026). Per share that is ₹1.52; our models calculate a fair value of ₹0.8700 per share.
What do the bullish and bearish scenarios say about SYMBIOX?
Our models span a range for Symbiox Investment & Trading Company Ltd: cautious scenario ₹0.6700, base ₹0.8700, optimistic ₹1.06 per share (as of Sep 29, 2026, price ₹1.52). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SYMBIOX?
Symbiox Investment & Trading Company Ltd trades at a price-to-earnings ratio of 30.4 (as of Sep 29, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹0.8700 is built from several models across several years. Other multiples: P/B 0.2, P/S 4.5, EV/EBITDA 26.9.
How solid is the balance sheet of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
Balance-sheet figures for Symbiox Investment & Trading Company Ltd (as of Sep 29, 2026): return on equity 0.5%. They feed the Quality Score of 73/100, which measures business quality independently of the share price.
How far is SYMBIOX from its 52-week high?
Symbiox Investment & Trading Company Ltd trades at ₹1.52, about 58% below its 52-week high of ₹3.59 and 4% above the low of ₹1.46 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹0.8700 is for.
Which stocks are comparable to Symbiox Investment & Trading Company Ltd?
From the same area (Consumer Cyclical) we also value Tongkun Group, Shenzhou International Group, Inner Mongolia ERDOS Resources Co, K.P.R. Mill Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Symbiox Investment & Trading Company Ltd stock attractive at the current price?
The data as of Sep 29, 2026: price ₹1.52, calculated fair value ₹0.8700 (−43%), Quality Score 73/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SYMBIOX calculated?
We run Symbiox Investment & Trading Company Ltd through 20 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹0.8700, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Symbiox Investment & Trading Company Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
The closing price on Oct 1, 2026 was ₹1.52. Our model-based fair value is ₹0.8700, about −43% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Symbiox Investment & Trading Company Ltd right now?
A high-quality business (quality 73/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (₹1.06). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Symbiox Investment & Trading Company Ltd
How large is the market capitalisation of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
The market capitalisation of Symbiox Investment & Trading Company Ltd is ₹62.6M (≈ $650K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
The price-to-sales ratio of Symbiox Investment & Trading Company Ltd is 2.89 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
Earnings per share at Symbiox Investment & Trading Company Ltd are ₹0.0500 (price ÷ EPS = P/E 30.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
The net margin of Symbiox Investment & Trading Company Ltd is 9.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
The return on equity (ROE) of Symbiox Investment & Trading Company Ltd is 0.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
On an EBIT basis the return on assets of Symbiox Investment & Trading Company Ltd is 0.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Symbiox Investment & Trading Company Ltd (SYMBIOX)?
The operating margin of Symbiox Investment & Trading Company Ltd is 40.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Symbiox Investment & Trading Company Ltd (SYMBIOX)?
Revenue at Symbiox Investment & Trading Company Ltd is growing −44.3% versus a year earlier (3y avg −26.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Symbiox Investment & Trading Company Ltd (SYMBIOX)?
Earnings per share at Symbiox Investment & Trading Company Ltd are growing +17.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Symbiox Investment & Trading Company Ltd (SYMBIOX) generate?
The free cash flow of Symbiox Investment & Trading Company Ltd is ₹27.3M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Symbiox Investment & Trading Company Ltd in the live analysis
One click puts Symbiox Investment & Trading Company Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
